Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Join laboratory hematologist Dr. Michael Krigstein in an 18-minute webinar exploring the critical role of Next-Generation Sequencing (NGS) in diagnosing and treating lymphoid malignancies. Learn how NGS technology has become essential for molecular testing in both myeloid and lymphoproliferative neoplasms, offering improved diagnostic classification, prognostication, and therapeutic target identification. Discover insights about achieving faster molecular results in lymphoid genomic profiling through the Ion Torrent Genexus System and Ion AmpliSeq™ Liverpool Lymphoid Network Panel. Gain valuable knowledge from Dr. Krigstein's expertise as a subspecialist in molecular hematology at St Vincent's Hospital in Sydney, drawing from his extensive research and publications in hematological malignancies. Healthcare professionals can earn PACE credits through Labroots upon completion of this educational presentation.
